Literature DB >> 24316971

Hematopoietic stem cells are acutely sensitive to Acd shelterin gene inactivation.

Morgan Jones, Gail Osawa, Joshua A Regal, Daniel N Weinberg, James Taggart, Hande Kocak, Ann Friedman, David O Ferguson, Catherine E Keegan, Ivan Maillard.   

Abstract

The shelterin complex plays dual functions in telomere homeostasis by recruiting telomerase and preventing the activation of a DNA damage response at telomeric ends. Somatic stem cells require telomerase activity, as evidenced by progressive stem cell loss leading to bone marrow failure in hereditary dyskeratosis congenita. Recent work demonstrates that dyskeratosis congenita can also arise from mutations in specific shelterin genes, although little is known about shelterin functions in somatic stem cells. We found that mouse hematopoietic stem cells (HSCs) are acutely sensitive to inactivation of the shelterin gene Acd, encoding TPP1. Homozygosity for a hypomorphic acd allele preserved the emergence and expansion of fetal HSCs but led to profoundly defective function in transplantation assays. Upon complete Acd inactivation, HSCs expressed p53 target genes, underwent cell cycle arrest, and were severely depleted within days, leading to hematopoietic failure. TPP1 loss induced increased telomeric fusion events in bone marrow progenitors. However, unlike in epidermal stem cells, p53 deficiency did not rescue TPP1-deficient HSCs, indicating that shelterin dysfunction has unique effects in different stem cell populations. Because the consequences of telomere shortening are progressive and unsynchronized, acute loss of shelterin function represents an attractive alternative for studying telomere crisis in hematopoietic progenitors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24316971      PMCID: PMC3967656          DOI: 10.1172/JCI67871

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  66 in total

1.  Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation.

Authors:  R A Greenberg; R C Allsopp; L Chin; G B Morin; R A DePinho
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

Review 2.  Mitochondria and cell death: outer membrane permeabilization and beyond.

Authors:  Stephen W G Tait; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2010-08-04       Impact factor: 94.444

3.  Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing.

Authors:  Matthias Stadtfeld; Thomas Graf
Journal:  Development       Date:  2004-12-02       Impact factor: 6.868

4.  Human RAP1 inhibits non-homologous end joining at telomeres.

Authors:  Jay Sarthy; Nancy S Bae; Jonathan Scrafford; Peter Baumann
Journal:  EMBO J       Date:  2009-09-17       Impact factor: 11.598

5.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).

Authors:  Utz Herbig; Wendy A Jobling; Benjamin P C Chen; David J Chen; John M Sedivy
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

6.  Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.

Authors:  Hua He; Yang Wang; Xiaolan Guo; Sonal Ramchandani; Jin Ma; Mei-Feng Shen; Dennis A Garcia; Yibin Deng; Asha S Multani; Mingjian James You; Sandy Chang
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

7.  Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.

Authors:  Fabian Beier; Miguel Foronda; Paula Martinez; Maria A Blasco
Journal:  Blood       Date:  2012-08-29       Impact factor: 22.113

8.  Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations.

Authors:  Tom J Vulliamy; Michael J Kirwan; Richard Beswick; Upal Hossain; Charlotte Baqai; Anna Ratcliffe; Judith Marsh; Amanda Walne; Inderjeet Dokal
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

9.  Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis.

Authors:  Tobias Else; Alessia Trovato; Alex C Kim; Yipin Wu; David O Ferguson; Rork D Kuick; Peter C Lucas; Gary D Hammer
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 38.585

10.  Mitochondrial localization of telomeric protein TIN2 links telomere regulation to metabolic control.

Authors:  Liuh-Yow Chen; Yi Zhang; Qinfen Zhang; Hongzhi Li; Zhenhua Luo; Hezhi Fang; Sok Ho Kim; Li Qin; Patricia Yotnda; Jianming Xu; Benjamin P Tu; Yidong Bai; Zhou Songyang
Journal:  Mol Cell       Date:  2012-08-09       Impact factor: 19.328

View more
  10 in total

Review 1.  The shelterin complex and hematopoiesis.

Authors:  Morgan Jones; Kamlesh Bisht; Sharon A Savage; Jayakrishnan Nandakumar; Catherine E Keegan; Ivan Maillard
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

Review 2.  Stem cell aging: mechanisms, regulators and therapeutic opportunities.

Authors:  Juhyun Oh; Yang David Lee; Amy J Wagers
Journal:  Nat Med       Date:  2014-08       Impact factor: 53.440

3.  Stem cell aging in adult progeria.

Authors:  Hoi-Hung Cheung; Duanqing Pei; Wai-Yee Chan
Journal:  Cell Regen (Lond)       Date:  2015-10-03

4.  Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1.

Authors:  Hande Kocak; Bari J Ballew; Kamlesh Bisht; Rebecca Eggebeen; Belynda D Hicks; Shalabh Suman; Adri O'Neil; Neelam Giri; Ivan Maillard; Blanche P Alter; Catherine E Keegan; Jayakrishnan Nandakumar; Sharon A Savage
Journal:  Genes Dev       Date:  2014-09-18       Impact factor: 12.890

Review 5.  Molecular mechanisms of telomere biology disorders.

Authors:  Sherilyn Grill; Jayakrishnan Nandakumar
Journal:  J Biol Chem       Date:  2020-11-22       Impact factor: 5.486

6.  High-throughput gene expression analysis identifies p53-dependent and -independent pathways contributing to the adrenocortical dysplasia (acd) phenotype.

Authors:  Ceren Sucularli; Peedikayil Thomas; Hande Kocak; James S White; Bridget C O'Connor; Catherine E Keegan
Journal:  Gene       Date:  2018-09-04       Impact factor: 3.913

Review 7.  The role of telomere binding molecules for normal and abnormal hematopoiesis.

Authors:  Kentaro Hosokawa; Fumio Arai
Journal:  Int J Hematol       Date:  2018-03-17       Impact factor: 2.319

8.  A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells.

Authors:  Jean-François Spinella; Pauline Cassart; Nicolas Garnier; Philippe Rousseau; Claire Drullion; Chantal Richer; Manon Ouimet; Virginie Saillour; Jasmine Healy; Chantal Autexier; Daniel Sinnett
Journal:  BMC Cancer       Date:  2015-09-07       Impact factor: 4.430

9.  The telomere binding protein Pot1 maintains haematopoietic stem cell activity with age.

Authors:  Kentaro Hosokawa; Ben D MacArthur; Yoshiko Matsumoto Ikushima; Hirofumi Toyama; Yoshikazu Masuhiro; Shigemasa Hanazawa; Toshio Suda; Fumio Arai
Journal:  Nat Commun       Date:  2017-10-06       Impact factor: 14.919

10.  TPP1 mutagenesis screens unravel shelterin interfaces and functions in hematopoiesis.

Authors:  Sherilyn Grill; Shilpa Padmanaban; Ann Friedman; Eric Perkey; Frederick Allen; Valerie M Tesmer; Jennifer Chase; Rami Khoriaty; Catherine E Keegan; Ivan Maillard; Jayakrishnan Nandakumar
Journal:  JCI Insight       Date:  2021-05-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.